News

Press Releases
Back to Press Releases >
BioRestorative Therapies to Present at LD Micro Conference
11/25/2013
BioRestorative Therapies
BioRestorative Therapies to Present at LD Micro Conference

 

JUPITER, Fla. (November 25, 2013) - BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCBB: BRTX), a life sciences company focused on adult stem cell-based cellular therapies for various personal medical applications, today announced that Mark Weinreb, the Company's president and chief executive officer, will present at the LD MICRO Conference on Wednesday, December 4th at 3:30 p.m. Pacific Time. The presentation will provide a corporate overview and a discussion of the Company's growth strategy.  The conference will be held at the Luxe Sunset Hotel at 11461 Sunset Blvd., Los Angeles, California.

 

Management will be available for one-on-one meetings with the investment community during the conference. Please contact LD Micro organizers if you would like to arrange a meeting.

 

 

About BioRestorative Therapies, Inc.

 

BioRestorative Therapies, Inc. (www.biorestorative.com) develops products and medical procedures using cell and tissue protocols, primarily involving adult stem cells, including:

 

·         brtxDISC(TM) (Disc Implanted Stem Cells) is an investigational non-surgical treatment for bulging and herniated lumbar discs that is intended for patients who have failed non-invasive procedures and face the prospect of surgery.  The treatment involves culturing a patient's own stem cells and then delivering them via a proprietary medical device to the damaged region of the disc in an outpatient procedure.

·         ThermoStem® is a treatment using brown fat stem cells that is under development for metabolic disorders including diabetes and obesity. Initial preclinical research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels.

·         brtx-C Cosmetic is based on the development of a human cellular extract that has been demonstrated in in vitro skin studies to increase the production of collagen and fibronectin, which are proteins that are essential to combating the aging of skin.  Potential cosmetic uses are being explored with third parties.

 

The Company also offers plant stem cell-based facial creams and beauty products under the Stem Pearls® brand at www.stempearls.com.

 

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including those set forth in the Company's Form 10-K filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.

 

Investor Contacts:

LHA

Kim Sutton Golodetz

212-838-3777

kgolodetz@lhai.com

or

Bruce Voss

310-691-7100

bvoss@lhai.com
 

#   #   #

BioRestorative Therapies: A Stem Cell Biotechnology Company